Playlist

Embassy of India in Ashgabat Announces Vacancy for Local Resource Person for Yoga

04 Aug. 09:56

Source

The Embassy of India invites applications for the position of Local Resource Person for Yoga. The selected candidate will conduct regular yoga sessions at the Embassy premises and at the Bagtyyarlyk Sports Complex in Ashgabat.

Applicants must be between 25 and 50 years of age, hold a minimum of a university graduation degree, be physically and mentally fit, and be fluent in Russian, Turkmen, and English. Candidates must possess either a minimum 3-year degree in Yoga with 3 years of teaching experience, or a 2-year diploma/certificate/training in Yoga from a renowned institution/Guru with 4 years of experience, along with adequate knowledge of Yoga history and philosophy. Desirable skills include computer proficiency (including audio/video processing), experience in live performances or lecture demonstrations, and strong initiative.

Interested candidates should submit their application along with a CV, work experience, and educational qualification documents to the Embassy of India, International Business Centre, Y. Emre 1, Mir 2/1, P.O. Box No. 80, Ashgabat-744017, Turkmenistan. The deadline for applications is August 14, 2026. For inquiries, the Embassy can be contacted on working days from 09:00 to 13:00 and 14:00 to 17:30 via phone (456152, 456153) or email (int.ashgabat@mea.gov.in / pic.ashgabat@mea.gov.in).

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌